Ventricular tachycardia characteristics and outcomes with catheter ablation vs. antiarrhythmic therapy: insights from the VANISH trial.
Marc William DeyellSteve DoucetteRatika ParkashIsabelle NaultLorne GulaChristopher GrayMartin GardnerLaurence D SternsJeff S HealeyVidal EssebagJohn L SappPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2022)
The VT cycle length can influence response to either ablation or escalated drug therapy in patients with VT and prior MI. Those with slow VT had improved outcomes with ablation. Patients presenting with electrical storm demonstrated similar outcomes to the overall trial population, with a trend to benefit of catheter ablation, particularly in those on amiodarone.
Keyphrases
- catheter ablation
- atrial fibrillation
- left atrial
- left atrial appendage
- study protocol
- clinical trial
- phase iii
- phase ii
- randomized controlled trial
- stem cells
- heart failure
- type diabetes
- left ventricular
- open label
- adipose tissue
- glycemic control
- mitral valve
- skeletal muscle
- smoking cessation
- electronic health record
- adverse drug